Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × OTHER × Orgasm × Clear all

Phase

Status

Withdrawn 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 282 Neoplasms 183 Prostatic Neoplasms 168 Carcinoma, Non-Small-Cell Lung 125 Lung Neoplasms 104 Pancreatic Neoplasms 96 Colorectal Neoplasms 96 Neoplasm Metastasis 82 Carcinoma, Hepatocellular 81 Leukemia, Myeloid, Acute 78 Brain Neoplasms 75 Multiple Myeloma 74 Head and Neck Neoplasms 67 Melanoma 63 Lymphoma 63 Ovarian Neoplasms 61 Glioblastoma 58 Leukemia 57 Leukemia, Lymphocytic, Chronic, B-Cell 55 Colonic Neoplasms 55 Precursor Cell Lymphoblastic Leukemia-Lymphoma 49 Recurrence 47 Rectal Neoplasms 46 Hematologic Neoplasms 43 Squamous Cell Carcinoma of Head and Neck 42 Glioma 40 Lymphoma, Non-Hodgkin 37 Lymphoma, Follicular 37 Carcinoma, Renal Cell 37 Lymphoma, Large B-Cell, Diffuse 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01724242 2017-11-28

Vaginal DHEA for Women After Breast Cancer

Hadassah Medical Organization

Phase 2/3 Withdrawn

Breast Neoplasms, Orgasm, Urinary Incontinence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡